Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Psychosocial impacts of hybrid closed‐loop systems in the management of diabetes: a review

Psychosocial impacts of hybrid closed‐loop systems in the management of diabetes: a review There is a pressing need for new treatment regimens that enable improved glycaemic control and reduced diabetes self‐management burdens. Closed‐loop, or artificial pancreas, systems represent one of the most promising avenues in this regard. Closed‐loop systems connect wearable continuous glucose monitor (CGM) sensors to smartphone‐ or tablet‐mounted algorithms that process and model CGM data to deliver precise and frequently updated doses of fast‐acting insulin (and glucagon in dual‐hormone systems) to users via wearable pumps. Recent studies have demonstrated that closed‐loop systems offer significant benefit in terms of improved glycaemic control. However, less attention has been paid to the psychosocial impact on users of closed‐loop systems. This article reviews recent research on psychosocial aspects of closed‐loop usage in light of preceding research on user experience of currently available technologies such as insulin pumps and CGM sensors. The small, but growing body of research in this field reports generally positive user experience and a number of experienced benefits including: reassurance and reduced anxiety, improved sleep and confidence, and ‘time off’ from diabetes demands. However, these benefits are counterbalanced by important challenges, ranging from variable levels of trust to concerns about physical bulk, technical glitches and difficulties incorporating closed‐loop systems into everyday life. Future research should explore psychosocial aspects of closed‐loop usage in more diverse groups and with regard to clinicians, as well as users, to ensure that the clinical benefits of closed‐loop systems are realized at scale in routine medical care. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetic Medicine Wiley

Psychosocial impacts of hybrid closed‐loop systems in the management of diabetes: a review

Farrington, C.
Diabetic Medicine , Volume 35 (4) – Jan 1, 2018
Download PDF
14 pages

Loading next page...
1
 
/lp/wiley/psychosocial-impacts-of-hybrid-closed-loop-systems-in-the-management-3KpcopjHQT

References (56)

Publisher
Wiley
Copyright
Diabetic Medicine © 2018 Diabetes UK
ISSN
0742-3071
eISSN
1464-5491
DOI
10.1111/dme.13567
Publisher site
See Article on Publisher Site

Abstract

There is a pressing need for new treatment regimens that enable improved glycaemic control and reduced diabetes self‐management burdens. Closed‐loop, or artificial pancreas, systems represent one of the most promising avenues in this regard. Closed‐loop systems connect wearable continuous glucose monitor (CGM) sensors to smartphone‐ or tablet‐mounted algorithms that process and model CGM data to deliver precise and frequently updated doses of fast‐acting insulin (and glucagon in dual‐hormone systems) to users via wearable pumps. Recent studies have demonstrated that closed‐loop systems offer significant benefit in terms of improved glycaemic control. However, less attention has been paid to the psychosocial impact on users of closed‐loop systems. This article reviews recent research on psychosocial aspects of closed‐loop usage in light of preceding research on user experience of currently available technologies such as insulin pumps and CGM sensors. The small, but growing body of research in this field reports generally positive user experience and a number of experienced benefits including: reassurance and reduced anxiety, improved sleep and confidence, and ‘time off’ from diabetes demands. However, these benefits are counterbalanced by important challenges, ranging from variable levels of trust to concerns about physical bulk, technical glitches and difficulties incorporating closed‐loop systems into everyday life. Future research should explore psychosocial aspects of closed‐loop usage in more diverse groups and with regard to clinicians, as well as users, to ensure that the clinical benefits of closed‐loop systems are realized at scale in routine medical care.

Journal

Diabetic Medicine – Wiley

Published: Jan 1, 2018

There are no references for this article.